ALNY Chart
- 52-Week Range: $120.42 - $209.29
- Market Capitalization: $15.50B
- Short Percentage: 0%
- Target Price: $208.20
- Shares Outstanding: 120.81M
- Next Earnings: Feb 3
Catalysts
CategoryCatalyst
Earnings
ALNY released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- See Why Did FDA Extend Review Period For Alnylam's Vutrisiran In AmyloidosisBenzinga | April 4th
- Alnylam Announces 3-Month Extension of Review Period for New Drug Application for VutrisiranBusiness Wire | April 4th
- Alnylam: Suing Moderna, Pfizer Over LNP Technology. There May Be Method In This MadnessSeeking Alpha | March 23rd
- Alnylam Pharmaceuticals' (ALNY) CEO Yvonne Greenstreet on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 10th
- Alnylam Clocks 76% Increase In Q4 Product Sales, Expects FY22 Product Sales Of Up To $1BBenzinga | February 10th
Company Info
Website: https://www.alnylam.com
Address: 675 West Kendall Street, Cambridge, MA, United States, 02142
Sector: Healthcare
Industry: Biotechnology
Full time employees: 1,665
Address: 675 West Kendall Street, Cambridge, MA, United States, 02142
Sector: Healthcare
Industry: Biotechnology
Full time employees: 1,665
$ALNY almost go time
$ALNY keep it going
$ALNY gonna come down hard today
$ALNY taking off soon
$ALNY I do it for the thrills!
$ALNY holding and buying these dips is so easy.
$ALNY When they tell me diversifying is for idiots
$ALNY I need a smoke after this trade
$ALNY whelp. you win this round. goodluck
$ALNY added more calls on that drop